Keratosis palmoplantaris cum degeneratione granulosaQ82.8

Author:Prof. Dr. med. Peter Altmeyer

Co-Autor:Alexandros Zarotis

All authors of this article

Last updated on: 21.12.2021

Dieser Artikel auf Deutsch

Synonym(s)

Epidermolytic palmoplantar keratosis; Palmoplantar keratosis epidermolytic

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Autosomal-dominantly inherited planar palmoplantar keratosis. Most likely, epidermolytic palmoplantar keratosis type Vörner (EPPK) and palmoplantar keratosis type Unna-Thost represent either clinically and genetically distinguishable variants of the same disease or they are one and the same disease(PPK type Unna-Thost-Vörner) whose clinical expression shows a certain variation due to the 26 possible underlying mutations in the KRT9 gene (17q12-q21).

In this respect, the historical nomenclature possibly only insufficiently differentiates and defines this spectrum of manifestations with regard to the phenotypic-genotypic correlation.

In contrast, keratosis palmoplantaris diffusa circumscripta type Norrbotten(synonyms: Non-epidermolytic palmoplantar keratoderma; autosomal dominant diffuse palmoplantar keratoderma, Norrbotten type;diffuse palmoplantar keratoderma, Bothnian type) as a diffuse palmoplantar keratosis with non-epidermolytic hyperkeratoses and with underlying mutation in the aquaporin-5 gene (AQP5, 12q13.12) occupies a genetically and phenotypically clearly defined special position.

Occurrence/EpidemiologyThis section has been translated automatically.

Most frequent palmoplantar keratosis with a prevalence of 1/40,000 births.

EtiopathogenesisThis section has been translated automatically.

Defective structure of keratin due to point mutations in the gene for keratin 9 (KRT9), which is mapped on chromosome 17q12-q21. Mutations in the KRT1 gene are rarer.

Keratin 9 is expressed in the suprabasal layers of the epidermis and is specific for the skin on the palms of the hands and soles of the feet. Mutations in the keratin 9 gene lead to the breakdown of the keratin filament network and cytolysis of corneocytes.

ManifestationThis section has been translated automatically.

Mostly occurring in early childhood.

Clinical featuresThis section has been translated automatically.

Diffuse, non-transgenic cornification with sharp edges, red rim and ankle-cushion-like hyperkeratosis on the extensor sides of hands and feet, also watch-glass nails. Occasionally hyperhidrosis palmaris or plantaris.

HistologyThis section has been translated automatically.

Acanthokeratolysis (see below degeneration, granular).

TherapyThis section has been translated automatically.

The treatment is difficult, because when the keratosis is completely detached, underlying, very touch-sensitive erythematous skin comes to the surface. The sensitivity to pain can go so far that the patient can no longer walk or touch anything. External therapy has priority, as this allows a better control of the keratolysis, i.e. only so much should be detached that good mobility is given and the occurrence of painful rhagades is prevented, but the sensitive areas remain sufficiently covered with a protective horny layer.

External therapyThis section has been translated automatically.

Softening and detachment of the horny layer is best achieved by physical and chemical methods (hot soft soap baths and corneal plane or rasp). Exteriors containing salicylic acid(e.g. 5% salicylic acid ointment) can be tried. However, they are often perceived as unpleasant. Recently, the local application of calcipotriol (e.g. psorcutane) is recommended.

Internal therapyThis section has been translated automatically.

Keratolysis cannot be adequately controlled by internal therapy. It is therefore not recommended.

LiteratureThis section has been translated automatically.

  1. Devos SA et al (2003) An unusual case of palmoplantar keratoderma. J Eur Acad Dermatol Venereol 17: 68-69
  2. Küster W et al (1995) Keratosis palmoplantaris diffusa Vörner. Dermatologist 46: 705-10
  3. Loh TH et al (2003) Palmar-plantar keratoderma of Unna Thost associated with atopic dermatitis: an underrecognized entity? Pediatric dermatol 20: 195-198
  4. Lucker GPH et al (1994) Topical calcipotriol in the treatment of epidermolytic palmoplantar keratoma of Vörner. Br J Dermatol 130: 543-5
  5. Maruyama R (1999) A case of Unna-Thost disease accompanied by Epidermophyton floccosum infection. J Dermatol 26: 63-66
  6. Mofid MZ et al (1998) Hereditary epidermolytic palmoplantar keratoderma (Vorner type) in a family with Ehlers-Danlos syndrome. J Am Acad Dermatol 38(5 Pt 2): 825-830
  7. Reis A et al (1994) Keratin 9 gene mutations in epidermolytic palmoplantar keratoderma (EPPK). Nat Genet 6: 174-179
  8. Thost A (1880) About hereditary ichtyosis palmaris et plantaris cornea. Dissertation (Heidelberg)
  9. Unna PG (1883) About the Keratoma palmare et planttare hereditarium. Quarterly Derm Syph (Vienna) 15: 231
  10. Vorner H (1901) For the knowledge of Keratoma hereditarium palmare et plantar. Arch Derm Syph 56: 3-31
  11. Yang JM (1998) Mutations in the 1A rod domain segment of the keratin 9 gene in epidermolytic palmoplantar keratoderma. Acta Derm Venereol 78: 412-416

Authors

Last updated on: 21.12.2021